|
UBE2W expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.121600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.078300E-02 |
| Normal-vs-Stage2 |
1.356270E-02 |
| Normal-vs-Stage3 |
2.306000E-02 |
| Normal-vs-Stage4 |
1.104860E-03 |
| Stage1-vs-Stage2 |
2.287400E-01 |
| Stage1-vs-Stage3 |
4.085400E-01 |
| Stage1-vs-Stage4 |
4.885800E-02 |
| Stage2-vs-Stage3 |
5.706200E-01 |
| Stage2-vs-Stage4 |
5.449200E-01 |
| Stage3-vs-Stage4 |
1.966970E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.797900E-02 |
| Normal-vs-AfricanAmerican |
4.198800E-01 |
| Normal-vs-Asian |
7.244900E-03 |
| Caucasian-vs-AfricanAmerican |
4.929200E-01 |
| Caucasian-vs-Asian |
2.685600E-01 |
| AfricanAmerican-vs-Asian |
1.820040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.741400E-03 |
| Normal-vs-Female |
4.608400E-02 |
| Male-vs-Female |
1.565830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.499600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.962200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.036900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.881400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.594200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.790300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.952000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.777200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.313400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.407200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.374400E-01 |
| Classical-VS-Follicular |
4.467900E-02 |
| Classical-VS-Other |
4.178000E-01 |
| Classical-VS-Normal |
9.889800E-02 |
| Tall-VS-Follicular |
2.815800E-01 |
| Tall-VS-Other |
4.177600E-01 |
| Tall-VS-Normal |
2.010200E-01 |
| Follicular-VS-Other |
9.104800E-01 |
| Follicular-VS-Normal |
7.061000E-03 |
| Other-VS-Normal |
1.262000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.901700E-03 |
| Normal-vs-N1 |
1.967980E-02 |
| N0-vs-N1 |
9.515800E-01 |
|
|
